S.A. Mason LLC Has $38,000 Stock Holdings in GRAIL, Inc. (NASDAQ:GRAL)

S.A. Mason LLC grew its holdings in shares of GRAIL, Inc. (NASDAQ:GRAL) by 50.1% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,499 shares of the company’s stock after buying an additional 500 shares during the quarter. S.A. Mason LLC’s holdings in GRAIL were worth $38,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in GRAL. Caldwell Sutter Capital Inc. acquired a new position in GRAIL during the 1st quarter valued at about $28,000. State of Tennessee Department of Treasury purchased a new position in shares of GRAIL during the fourth quarter valued at approximately $28,000. Lindbrook Capital LLC bought a new stake in GRAIL during the fourth quarter worth $28,000. Sterling Capital Management LLC bought a new stake in GRAIL during the fourth quarter worth $29,000. Finally, Wellington Shields Capital Management LLC purchased a new stake in GRAIL in the 4th quarter valued at $33,000.

Insiders Place Their Bets

In other GRAIL news, President Joshua J. Ofman sold 48,213 shares of the stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $33.93, for a total transaction of $1,635,867.09. Following the completion of the transaction, the president now directly owns 511,460 shares of the company’s stock, valued at approximately $17,353,837.80. This represents a 8.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Aaron Freidin sold 41,150 shares of the firm’s stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $33.93, for a total value of $1,396,219.50. Following the completion of the sale, the chief financial officer now directly owns 294,020 shares of the company’s stock, valued at $9,976,098.60. This represents a 12.28% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 183,398 shares of company stock valued at $6,222,694.

GRAIL Trading Up 2.0%

Shares of GRAIL stock opened at $43.95 on Wednesday. The business’s fifty day simple moving average is $37.98 and its 200 day simple moving average is $31.32. GRAIL, Inc. has a 12 month low of $12.33 and a 12 month high of $63.99. The firm has a market capitalization of $1.58 billion and a P/E ratio of -0.72.

GRAIL (NASDAQ:GRAL) last announced its earnings results on Tuesday, May 13th. The company reported ($3.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.03) by $0.93. The firm had revenue of $31.84 million during the quarter, compared to analyst estimates of $35.80 million. GRAIL had a negative return on equity of 17.99% and a negative net margin of 1,464.53%. Analysts predict that GRAIL, Inc. will post -15.15 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on GRAL shares. Morgan Stanley lifted their price objective on shares of GRAIL from $16.00 to $20.00 and gave the stock an “equal weight” rating in a report on Tuesday, March 18th. Canaccord Genuity Group boosted their price target on shares of GRAIL from $32.00 to $43.00 and gave the stock a “buy” rating in a report on Wednesday, May 14th.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.